Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 30,664 shares at $24.39 ($748K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $748k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.39 | 15,000 | $366K | 48.9% |
| 2 | $24.41 | 15,664 | $382K | 51.1% |
| Total | $24.40 avg | 30,664 | $748K | 100% |
| Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |
| HLVX | SELL | 2024-02-12 | $346K | — | Filing → |